US Patent Issued to Eliksa Therapeutics on March 31 for "Methods of treating epidermolysis bullosa with cell-free amniotic fluid compositions" (Pennsylvania Inventor)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,120, issued on March 31, was assigned to Eliksa Therapeutics Inc. (Doylestown, Pa.).

"Methods of treating epidermolysis bullosa with cell-free amniotic fluid compositions" was invented by Armen A. Karamanian (Newtown, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of treating a subject having epidermolysis bullosa, comprising administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising amniotic fluid substantially free of endogenous cells."

The patent was filed on Oct. 12, 2022, under Application No. 17/964,403.

*For further information, including images, charts and tab...